chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Intensive care, Pneumonia bacterial, Pyrexia, Respiratory distress
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/14/2021 and 2/2/2021. Patient contacted physician office on 8/9/2021 stating had a positive COVID HOME test on 8/8/2021 with a three day history of sore throat, headache, congestion, coughing also noted to have oxygen level of 81 and fever of 101.9. Patient was retested on 8/10/2021 and was positive. Patient presented to ED on 8/10/2021 with complaints of shortness of breath.  On presentation SpO2 100% on room air without significant tachypnea, but with mild bilateral wheezes. Patient received Imdevimab+casirivimab and was discharged home @ 1645. Patient presented back to ED at 2011 in  respiratory distress with increased work of breathing, accessory muscle use, and transient hypoxia. Noted O2 sats of 74% on room air, and placed on high-flow nasal cannula. Patient improved rapidly overnight coming down to just 2 L NC by the following morning. Patient stated she felt better as well denying SOB, fevers or chills but reporting some cough. Patient O2 needs had decreased to 4 L on ambulation by 8/13. She was discharged on home with home O2 on 8/13. She was prescribed dexamethasone to complete a total of 10 days of therapy for COVID and cefdinir to complete 5 days of therapy for suspected overlying bacterial PNA. Patient presented to ED on 8/14/2021 due to shortness of breath. She was  transferred to ICU 8/15 due to acute hypoxic respiratory failure due to COVID-19 pneumonia and found to have secondary bacterial pna.  Patient returned to the floor in hosptial but subsequently bounced back to the ICU 8/25 and intubated 8/26.  Patient continued to deteriorate and palliative care was consulted.  8/31 decision was made by family to pursue DNR/AND.  Patient passed away peacefully at 8:54PM on 8/31/2021.
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Respiratory tract congestion, SARS-CoV-2 test positive, Use of accessory respiratory muscles, Wheezing
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/14/2021 and 2/2/2021. Patient contacted physician office on 8/9/2021 stating had a positive COVID HOME test on 8/8/2021 with a three day history of sore throat, headache, congestion, coughing also noted to have oxygen level of 81 and fever of 101.9. Patient was retested on 8/10/2021 and was positive. Patient presented to ED on 8/10/2021 with complaints of shortness of breath.  On presentation SpO2 100% on room air without significant tachypnea, but with mild bilateral wheezes. Patient received Imdevimab+casirivimab and was discharged home @ 1645. Patient presented back to ED at 2011 in  respiratory distress with increased work of breathing, accessory muscle use, and transient hypoxia. Noted O2 sats of 74% on room air, and placed on high-flow nasal cannula. Patient improved rapidly overnight coming down to just 2 L NC by the following morning. Patient stated she felt better as well denying SOB, fevers or chills but reporting some cough. Patient O2 needs had decreased to 4 L on ambulation by 8/13. She was discharged on home with home O2 on 8/13. She was prescribed dexamethasone to complete a total of 10 days of therapy for COVID and cefdinir to complete 5 days of therapy for suspected overlying bacterial PNA. Patient presented to ED on 8/14/2021 due to shortness of breath. She was  transferred to ICU 8/15 due to acute hypoxic respiratory failure due to COVID-19 pneumonia and found to have secondary bacterial pna.  Patient returned to the floor in hosptial but subsequently bounced back to the ICU 8/25 and intubated 8/26.  Patient continued to deteriorate and palliative care was consulted.  8/31 decision was made by family to pursue DNR/AND.  Patient passed away peacefully at 8:54PM on 8/31/2021.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Amnesia, Arthralgia, Chest pain, Condition aggravated
Clinical narrative: Strange taste in mouth immediately, pain in injection arm, stinging pain in lower part of injection arm and in calf muscle, dizziness, tinnitus, abdominal pain, constipation, brain fog, memory loss, chest pain, forgetfulness, headache, earache in both inside and outside of both ears, ribs hurt, dryness in mouth, sore throat, nightmares, trouble sleeping, joint pain, muscle pain, fatigue
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Constipation, Dizziness, Dry mouth, Dysgeusia, Ear pain
Clinical narrative: Strange taste in mouth immediately, pain in injection arm, stinging pain in lower part of injection arm and in calf muscle, dizziness, tinnitus, abdominal pain, constipation, brain fog, memory loss, chest pain, forgetfulness, headache, earache in both inside and outside of both ears, ribs hurt, dryness in mouth, sore throat, nightmares, trouble sleeping, joint pain, muscle pain, fatigue
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: External ear pain, Fatigue, Feeling abnormal, Headache, Immediate post-injection reaction
Clinical narrative: Strange taste in mouth immediately, pain in injection arm, stinging pain in lower part of injection arm and in calf muscle, dizziness, tinnitus, abdominal pain, constipation, brain fog, memory loss, chest pain, forgetfulness, headache, earache in both inside and outside of both ears, ribs hurt, dryness in mouth, sore throat, nightmares, trouble sleeping, joint pain, muscle pain, fatigue
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Memory impairment, Musculoskeletal chest pain, Myalgia, Nightmare
Clinical narrative: Strange taste in mouth immediately, pain in injection arm, stinging pain in lower part of injection arm and in calf muscle, dizziness, tinnitus, abdominal pain, constipation, brain fog, memory loss, chest pain, forgetfulness, headache, earache in both inside and outside of both ears, ribs hurt, dryness in mouth, sore throat, nightmares, trouble sleeping, joint pain, muscle pain, fatigue
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain, Pain in extremity, Tinnitus
Clinical narrative: Strange taste in mouth immediately, pain in injection arm, stinging pain in lower part of injection arm and in calf muscle, dizziness, tinnitus, abdominal pain, constipation, brain fog, memory loss, chest pain, forgetfulness, headache, earache in both inside and outside of both ears, ribs hurt, dryness in mouth, sore throat, nightmares, trouble sleeping, joint pain, muscle pain, fatigue
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Imaging procedure abnormal, Retinal detachment, Scleral buckling surgery
Clinical narrative: I experienced a retinal detachment on August 11, 2021. I had emergency scleral buckle surgery the next morning. I am not sure if this is related to the vaccine but I wanted to report that I had this health event in case it is.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Brain natriuretic peptide normal, Chest pain, Computerised tomogram normal, Echocardiogram, Electrocardiogram normal
Clinical narrative: Chest pain which got worse over a few days, reached a maximum around one week after, and gradually subsided. For several weeks the pain got more intense when lying down, elevating limbs, or doing any activity. 13 weeks after, still get occasional slight pain with high exertion or elevating limbs.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer normal, Laboratory test, Pain, Red blood cell sedimentation rate normal, Troponin normal
Clinical narrative: Chest pain which got worse over a few days, reached a maximum around one week after, and gradually subsided. For several weeks the pain got more intense when lying down, elevating limbs, or doing any activity. 13 weeks after, still get occasional slight pain with high exertion or elevating limbs.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Client age 12 accidentally received Johnson and Johnson Vaccine instead of Pfizer. Parent aware of situation. Medical director was notified immediately concerning incident. MD spoke with parent. Md to follow up with parent/child, instructed to monitor child closely for any reactions. Child and parent instructed to wait for 30 minutes. After 30 minutes no reported symptoms of adverse reaction noted. Md indicated would continue to follow up with parent for any changes noted.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Left side of face went completely numb and right hand went completely numb for several hours.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Daily headache it started mid August. over my left temple.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphagia, Lip swelling, Tachycardia, Tremor, Urticaria
Clinical narrative: Difficulty swallowing, felt like her lips were getting swollen, Tachycardic, Hive to neck and chin.  She also began shaking uncontrollably
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Diarrhoea
Clinical narrative: diarrhea and abdominal pain, ongoing for 24 hours so far, not severe enough for treatment at this point
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Blood creatine phosphokinase increased, Chest X-ray normal, Chest pain, Chills, Dyspnoea
Clinical narrative: Chest pain and shortness of breath following cross country practice.  Developed myalgias, headache and hyperventilation.  Subjective fever and chills.  Seen ED,  Afebrile, SaO2 100% on room air.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram normal, Full blood count normal, Headache, Hyperventilation, Metabolic function test normal
Clinical narrative: Chest pain and shortness of breath following cross country practice.  Developed myalgias, headache and hyperventilation.  Subjective fever and chills.  Seen ED,  Afebrile, SaO2 100% on room air.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: Chest pain and shortness of breath following cross country practice.  Developed myalgias, headache and hyperventilation.  Subjective fever and chills.  Seen ED,  Afebrile, SaO2 100% on room air.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: 1)  tinnitus/ringing in both ears - persistent
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Swollen tongue, Throat tightness
Clinical narrative: Vaccine was around 5PM, close to 30 minutes later, throat felt tight. Quickly got tighter until I felt like I couldn't breathe. Tongue  and side of next was swollen. Crushed two benadryl and put under tongue.  Went to ER and was monitored for a few hours. Was advised not to get second dose at the Hospital, and my main Dr. agree. Went home around 9PM.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Dizziness, Heart rate increased, Upper respiratory tract infection, X-ray
Clinical narrative: Heart was beating fast and wouldn't slow down, got dizzy , went to  ER at hospital
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Confusional state, Fatigue, Rhinorrhoea
Clinical narrative: Admitted 8/22/2021 with Covid symptoms: runny nose, fatigue, new confusion or inability to be woken.  Onset of symptoms 8/18/2021. Not in ICU or intubated.  Submitter does not have access to further details or medical records.
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sleep disorder
Clinical narrative: Admitted 8/22/2021 with Covid symptoms: runny nose, fatigue, new confusion or inability to be woken.  Onset of symptoms 8/18/2021. Not in ICU or intubated.  Submitter does not have access to further details or medical records.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Night sweats, SARS-CoV-2 test positive
Clinical narrative: night sweat and coughing
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Condition aggravated, Dizziness, Feeling abnormal, Migraine
Clinical narrative: Vomiting, migraine increase, dizziness, nausea, unsteadiness, ?brain fog?.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: Vomiting, migraine increase, dizziness, nausea, unsteadiness, ?brain fog?.
Age: 12.0
Sex: F
Vaccine: HPV9
Symptoms: Blepharospasm, Blindness, Blood bicarbonate normal, Blood calcium normal, Blood chloride normal
Clinical narrative: Patient presented with eye blinking, vision loss, and tremors of arms/legs initially concerning for seizures, on 6/27/21. Had a normal EEG on 7/15/21 and an MRI on 8/10/21 which showed "BRAIN PARENCHYMA: No acute infarct or mass.   Small focus of T2 hyperintense signal within subcortical white matter of left superior frontal gyrus anteriorly, with indistinct gray-white differentiation." Proceeded to have ongoing episodes with eye blinking, extremity shaking, but preserved consciousness, sometimes with vision loss in July, August and early Sept 2021. Presented to the ED on 9/4/21 for increased frequency of eye fluttering and hand twitching, started on Keppra.  Returned to ED on 9/6/21 for new episodes of breath holding, eyes closing, but no loss of consciousness. Admitted for monitoring at that time and had another EEG on 9/7/21 which was also normal. During admission had addition of loss of tone with episodes. Seen by Neurology, and Psychology services. Felt that based on description and videos of episodes, they were unlikely to be seizures and Keppra was stopped on 9/8/21 without increase in episodes..Has  ongoing evaluation for periodic paralysis syndromes, cataplexy, and functional neurologic disorder.
Age: 12.0
Sex: F
Vaccine: HPV9
Symptoms: Blood creatinine normal, Blood glucose normal, Blood magnesium normal, Blood phosphorus normal, Blood potassium normal
Clinical narrative: Patient presented with eye blinking, vision loss, and tremors of arms/legs initially concerning for seizures, on 6/27/21. Had a normal EEG on 7/15/21 and an MRI on 8/10/21 which showed "BRAIN PARENCHYMA: No acute infarct or mass.   Small focus of T2 hyperintense signal within subcortical white matter of left superior frontal gyrus anteriorly, with indistinct gray-white differentiation." Proceeded to have ongoing episodes with eye blinking, extremity shaking, but preserved consciousness, sometimes with vision loss in July, August and early Sept 2021. Presented to the ED on 9/4/21 for increased frequency of eye fluttering and hand twitching, started on Keppra.  Returned to ED on 9/6/21 for new episodes of breath holding, eyes closing, but no loss of consciousness. Admitted for monitoring at that time and had another EEG on 9/7/21 which was also normal. During admission had addition of loss of tone with episodes. Seen by Neurology, and Psychology services. Felt that based on description and videos of episodes, they were unlikely to be seizures and Keppra was stopped on 9/8/21 without increase in episodes..Has  ongoing evaluation for periodic paralysis syndromes, cataplexy, and functional neurologic disorder.
Age: 12.0
Sex: F
Vaccine: HPV9
Symptoms: Blood sodium normal, Blood urea normal, Borrelia test negative, Breath holding, Cataplexy
Clinical narrative: Patient presented with eye blinking, vision loss, and tremors of arms/legs initially concerning for seizures, on 6/27/21. Had a normal EEG on 7/15/21 and an MRI on 8/10/21 which showed "BRAIN PARENCHYMA: No acute infarct or mass.   Small focus of T2 hyperintense signal within subcortical white matter of left superior frontal gyrus anteriorly, with indistinct gray-white differentiation." Proceeded to have ongoing episodes with eye blinking, extremity shaking, but preserved consciousness, sometimes with vision loss in July, August and early Sept 2021. Presented to the ED on 9/4/21 for increased frequency of eye fluttering and hand twitching, started on Keppra.  Returned to ED on 9/6/21 for new episodes of breath holding, eyes closing, but no loss of consciousness. Admitted for monitoring at that time and had another EEG on 9/7/21 which was also normal. During admission had addition of loss of tone with episodes. Seen by Neurology, and Psychology services. Felt that based on description and videos of episodes, they were unlikely to be seizures and Keppra was stopped on 9/8/21 without increase in episodes..Has  ongoing evaluation for periodic paralysis syndromes, cataplexy, and functional neurologic disorder.
Age: 12.0
Sex: F
Vaccine: HPV9
Symptoms: Cerebral calcification, Conversion disorder, Electroencephalogram normal, Excessive eye blinking, Eyelid disorder
Clinical narrative: Patient presented with eye blinking, vision loss, and tremors of arms/legs initially concerning for seizures, on 6/27/21. Had a normal EEG on 7/15/21 and an MRI on 8/10/21 which showed "BRAIN PARENCHYMA: No acute infarct or mass.   Small focus of T2 hyperintense signal within subcortical white matter of left superior frontal gyrus anteriorly, with indistinct gray-white differentiation." Proceeded to have ongoing episodes with eye blinking, extremity shaking, but preserved consciousness, sometimes with vision loss in July, August and early Sept 2021. Presented to the ED on 9/4/21 for increased frequency of eye fluttering and hand twitching, started on Keppra.  Returned to ED on 9/6/21 for new episodes of breath holding, eyes closing, but no loss of consciousness. Admitted for monitoring at that time and had another EEG on 9/7/21 which was also normal. During admission had addition of loss of tone with episodes. Seen by Neurology, and Psychology services. Felt that based on description and videos of episodes, they were unlikely to be seizures and Keppra was stopped on 9/8/21 without increase in episodes..Has  ongoing evaluation for periodic paralysis syndromes, cataplexy, and functional neurologic disorder.
Age: 12.0
Sex: F
Vaccine: HPV9
Symptoms: Full blood count normal, Hypotonia, Laboratory test normal, Magnetic resonance imaging head abnormal, Muscle twitching
Clinical narrative: Patient presented with eye blinking, vision loss, and tremors of arms/legs initially concerning for seizures, on 6/27/21. Had a normal EEG on 7/15/21 and an MRI on 8/10/21 which showed "BRAIN PARENCHYMA: No acute infarct or mass.   Small focus of T2 hyperintense signal within subcortical white matter of left superior frontal gyrus anteriorly, with indistinct gray-white differentiation." Proceeded to have ongoing episodes with eye blinking, extremity shaking, but preserved consciousness, sometimes with vision loss in July, August and early Sept 2021. Presented to the ED on 9/4/21 for increased frequency of eye fluttering and hand twitching, started on Keppra.  Returned to ED on 9/6/21 for new episodes of breath holding, eyes closing, but no loss of consciousness. Admitted for monitoring at that time and had another EEG on 9/7/21 which was also normal. During admission had addition of loss of tone with episodes. Seen by Neurology, and Psychology services. Felt that based on description and videos of episodes, they were unlikely to be seizures and Keppra was stopped on 9/8/21 without increase in episodes..Has  ongoing evaluation for periodic paralysis syndromes, cataplexy, and functional neurologic disorder.
Age: 12.0
Sex: F
Vaccine: HPV9
Symptoms: Paralysis, SARS-CoV-2 test negative, Tremor, White matter lesion
Clinical narrative: Patient presented with eye blinking, vision loss, and tremors of arms/legs initially concerning for seizures, on 6/27/21. Had a normal EEG on 7/15/21 and an MRI on 8/10/21 which showed "BRAIN PARENCHYMA: No acute infarct or mass.   Small focus of T2 hyperintense signal within subcortical white matter of left superior frontal gyrus anteriorly, with indistinct gray-white differentiation." Proceeded to have ongoing episodes with eye blinking, extremity shaking, but preserved consciousness, sometimes with vision loss in July, August and early Sept 2021. Presented to the ED on 9/4/21 for increased frequency of eye fluttering and hand twitching, started on Keppra.  Returned to ED on 9/6/21 for new episodes of breath holding, eyes closing, but no loss of consciousness. Admitted for monitoring at that time and had another EEG on 9/7/21 which was also normal. During admission had addition of loss of tone with episodes. Seen by Neurology, and Psychology services. Felt that based on description and videos of episodes, they were unlikely to be seizures and Keppra was stopped on 9/8/21 without increase in episodes..Has  ongoing evaluation for periodic paralysis syndromes, cataplexy, and functional neurologic disorder.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Condition aggravated, Death, General physical health deterioration, Hypoxia
Clinical narrative: Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 1/14/2021 and 2/12/2021. Presented to ED on 8/16/2021 with complaints of worsening hypoxia after a positive COVID test the previous week from an outside facility. Symptom onset was 8/11/2021. Patient has been on 5L NC at baseline for pulmonary fibrosis. Patient treated with dexamethasone, remdesivir, and highflow oxygen. Patient initially improved after 5 days of remdesivir and 10 days of dexamethasone, but hypoxia worsened starting on 8/30/2021. On 9/3/2021 patient rapidly deteriorated, and expired at 1545 on 9/3/2021.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pulmonary fibrosis, SARS-CoV-2 test positive
Clinical narrative: Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 1/14/2021 and 2/12/2021. Presented to ED on 8/16/2021 with complaints of worsening hypoxia after a positive COVID test the previous week from an outside facility. Symptom onset was 8/11/2021. Patient has been on 5L NC at baseline for pulmonary fibrosis. Patient treated with dexamethasone, remdesivir, and highflow oxygen. Patient initially improved after 5 days of remdesivir and 10 days of dexamethasone, but hypoxia worsened starting on 8/30/2021. On 9/3/2021 patient rapidly deteriorated, and expired at 1545 on 9/3/2021.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Burning sensation, Muscle twitching, Neuropathy peripheral, Pruritus
Clinical narrative: Approximately 2 weeks after receiving my 2nd shot I started experiencing short pulses at the top of my head in various spots. I did not have a headache. Then I experienced neuropathy symptoms - itching and burning at the top of my head. This condition lasted for approximately 4 months - till the end of July. The condition was reported to my Primary Care Physician on 5/25/21. All symptoms have disappeared with no long term adverse effects.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood pressure abnormal, COVID-19, Cough, Death, Decreased appetite
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 4/7/2021 and 4/30/2021. Presented to ED on 8/17/2021 with cough, nausea, vomiting, diarrhea fever of 102, loss of appetite, and decreased UOP. Treated initially for DKA, and placed on HFNC. DKA resolved, and transitioned off insulin gtt 8/21. Due to increasing oxygen requirements, patient intubated on 8/23, and subsequently required proning. Developed septic shock, requiring norepinephrine and vasopressin gtt. Worsening renal function prompted Vascath placement and initiation of dialysis 8/29. Patient continued to deteriorate clinically, requiring the addition of epinephrine for blood pressure support, and worsening respiratory acidosis and hypoxemia. He developed wide complex tachycardia requiring 1 shock, after which family was called for goals of care discussion. Transitioned patient to comfort care, and he expired shortly thereafter.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Diabetic ketoacidosis, Dialysis, Diarrhoea, Endotracheal intubation, General physical health deterioration
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 4/7/2021 and 4/30/2021. Presented to ED on 8/17/2021 with cough, nausea, vomiting, diarrhea fever of 102, loss of appetite, and decreased UOP. Treated initially for DKA, and placed on HFNC. DKA resolved, and transitioned off insulin gtt 8/21. Due to increasing oxygen requirements, patient intubated on 8/23, and subsequently required proning. Developed septic shock, requiring norepinephrine and vasopressin gtt. Worsening renal function prompted Vascath placement and initiation of dialysis 8/29. Patient continued to deteriorate clinically, requiring the addition of epinephrine for blood pressure support, and worsening respiratory acidosis and hypoxemia. He developed wide complex tachycardia requiring 1 shock, after which family was called for goals of care discussion. Transitioned patient to comfort care, and he expired shortly thereafter.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypoxia, Nausea, Prone position, Pyrexia, Renal impairment
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 4/7/2021 and 4/30/2021. Presented to ED on 8/17/2021 with cough, nausea, vomiting, diarrhea fever of 102, loss of appetite, and decreased UOP. Treated initially for DKA, and placed on HFNC. DKA resolved, and transitioned off insulin gtt 8/21. Due to increasing oxygen requirements, patient intubated on 8/23, and subsequently required proning. Developed septic shock, requiring norepinephrine and vasopressin gtt. Worsening renal function prompted Vascath placement and initiation of dialysis 8/29. Patient continued to deteriorate clinically, requiring the addition of epinephrine for blood pressure support, and worsening respiratory acidosis and hypoxemia. He developed wide complex tachycardia requiring 1 shock, after which family was called for goals of care discussion. Transitioned patient to comfort care, and he expired shortly thereafter.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Respiratory acidosis, Resuscitation, SARS-CoV-2 test positive, Septic shock, Tachycardia
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 4/7/2021 and 4/30/2021. Presented to ED on 8/17/2021 with cough, nausea, vomiting, diarrhea fever of 102, loss of appetite, and decreased UOP. Treated initially for DKA, and placed on HFNC. DKA resolved, and transitioned off insulin gtt 8/21. Due to increasing oxygen requirements, patient intubated on 8/23, and subsequently required proning. Developed septic shock, requiring norepinephrine and vasopressin gtt. Worsening renal function prompted Vascath placement and initiation of dialysis 8/29. Patient continued to deteriorate clinically, requiring the addition of epinephrine for blood pressure support, and worsening respiratory acidosis and hypoxemia. He developed wide complex tachycardia requiring 1 shock, after which family was called for goals of care discussion. Transitioned patient to comfort care, and he expired shortly thereafter.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Urine output decreased, Vascular catheterisation, Vomiting
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 4/7/2021 and 4/30/2021. Presented to ED on 8/17/2021 with cough, nausea, vomiting, diarrhea fever of 102, loss of appetite, and decreased UOP. Treated initially for DKA, and placed on HFNC. DKA resolved, and transitioned off insulin gtt 8/21. Due to increasing oxygen requirements, patient intubated on 8/23, and subsequently required proning. Developed septic shock, requiring norepinephrine and vasopressin gtt. Worsening renal function prompted Vascath placement and initiation of dialysis 8/29. Patient continued to deteriorate clinically, requiring the addition of epinephrine for blood pressure support, and worsening respiratory acidosis and hypoxemia. He developed wide complex tachycardia requiring 1 shock, after which family was called for goals of care discussion. Transitioned patient to comfort care, and he expired shortly thereafter.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Fatigue, Headache
Clinical narrative: Felt Feverish, Dry Cough, Sore Throat, Shortness of Breath, Headaches, Muscle  Aches, Other  Fatigue, Nasal congestion
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza A virus test negative, Influenza B virus test, Influenza virus test negative, Myalgia, Nasal congestion
Clinical narrative: Felt Feverish, Dry Cough, Sore Throat, Shortness of Breath, Headaches, Muscle  Aches, Other  Fatigue, Nasal congestion
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pyrexia, Respiratory syncytial virus test negative, SARS-CoV-2 test positive
Clinical narrative: Felt Feverish, Dry Cough, Sore Throat, Shortness of Breath, Headaches, Muscle  Aches, Other  Fatigue, Nasal congestion
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Malaise, Vaccine breakthrough infection
Clinical narrative: Vaccine breakthrough, symptomatic,   Inpatient admit 9/2-9/9.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Erythema
Clinical narrative: Right breast pink/red/soar for 3 days.  Areola was painful and  red/pink.
Age: 24.0
Sex: F
Vaccine: MENB
Symptoms: Injection site erythema, Injection site nodule, Injection site pain, Injection site warmth
Clinical narrative: At first my entire upper left arm became red, hot, and tender within a day of receiving the shot. After a few days, it became an isolated red bump (~2 inches diameter?) that is still red, hot, and tender. It is only sore if I touch it. This bump hasn't changed for the past 1.5 weeks.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Blood pressure increased
Clinical narrative: Patient experience an anxiety attack about 20 minutes post vaccination. He had elevated BP of 170/120 intially and requested EMT services. EMT came 10 minutes later and attended to the patient. His BP was 140/120 at that time and they determined he was stable. The offered to drive him home. Patinet refused. Patient's mother offered to drive him home but he also refused. She followed him driving home.
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Blood urine present, COVID-19, Chills, Cough
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/18/2021 and 4/15/2021. Presented to ED on 8/16/2021 with complaints of weakness and fever over the past day. Patient's nephrostomy tube was changed two weeks prior for an infected kidney stone and patient just started noticing blood in his foley bag the morning of presenting to the ED. Admitted for UTI. On 8/17/2021 patient expressed concern for COVID status since family at home is COVID positive. Patient has mild cough but feels it is chronic at baseline. Patient tested positive for COVID on 8/18/2021 and spiked a fever that afternoon. On 8/19/2021 patient reported feeling cold and having chills overnight as well as dry cough, but denies shortness of breath. On 8/20/2021 patients SPO2 dropped (86-88%) on 6L O2. Patient was placed on NRB with 96% sats. On 8/21 patient on HFNC with escalating oxygen requirements, patient started on dexamethasone. On 8/25 patient experienced destauration to 87% while on 6L NC. On 8/30/2021 patient wished to discuss comfort care. On 8/31/2021 patient was transitioned to inpatient hospice, and patient expired on 9/1/2021.
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Culture urine positive, Death, Escherichia test positive, Feeling cold, Nephrolithiasis
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/18/2021 and 4/15/2021. Presented to ED on 8/16/2021 with complaints of weakness and fever over the past day. Patient's nephrostomy tube was changed two weeks prior for an infected kidney stone and patient just started noticing blood in his foley bag the morning of presenting to the ED. Admitted for UTI. On 8/17/2021 patient expressed concern for COVID status since family at home is COVID positive. Patient has mild cough but feels it is chronic at baseline. Patient tested positive for COVID on 8/18/2021 and spiked a fever that afternoon. On 8/19/2021 patient reported feeling cold and having chills overnight as well as dry cough, but denies shortness of breath. On 8/20/2021 patients SPO2 dropped (86-88%) on 6L O2. Patient was placed on NRB with 96% sats. On 8/21 patient on HFNC with escalating oxygen requirements, patient started on dexamethasone. On 8/25 patient experienced destauration to 87% while on 6L NC. On 8/30/2021 patient wished to discuss comfort care. On 8/31/2021 patient was transitioned to inpatient hospice, and patient expired on 9/1/2021.
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Nephrostomy, Oxygen saturation decreased, Pyrexia, SARS-CoV-2 test positive, Urinary tract infection
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/18/2021 and 4/15/2021. Presented to ED on 8/16/2021 with complaints of weakness and fever over the past day. Patient's nephrostomy tube was changed two weeks prior for an infected kidney stone and patient just started noticing blood in his foley bag the morning of presenting to the ED. Admitted for UTI. On 8/17/2021 patient expressed concern for COVID status since family at home is COVID positive. Patient has mild cough but feels it is chronic at baseline. Patient tested positive for COVID on 8/18/2021 and spiked a fever that afternoon. On 8/19/2021 patient reported feeling cold and having chills overnight as well as dry cough, but denies shortness of breath. On 8/20/2021 patients SPO2 dropped (86-88%) on 6L O2. Patient was placed on NRB with 96% sats. On 8/21 patient on HFNC with escalating oxygen requirements, patient started on dexamethasone. On 8/25 patient experienced destauration to 87% while on 6L NC. On 8/30/2021 patient wished to discuss comfort care. On 8/31/2021 patient was transitioned to inpatient hospice, and patient expired on 9/1/2021.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Body temperature abnormal, COVID-19, Cough, Fatigue
Clinical narrative: Urgent care, CovID test positive, Aches and temp 100.3, fatigue, weakness, Cough with clear drainage. Son and daughter had the same symptoms but did not take a vaccination at that time. Went to see the doctor early because of health conditions. Zpak 5day supply and fluids. D3, C, Zinc, Antihistamine.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, SARS-CoV-2 test positive, Sinus operation
Clinical narrative: Urgent care, CovID test positive, Aches and temp 100.3, fatigue, weakness, Cough with clear drainage. Son and daughter had the same symptoms but did not take a vaccination at that time. Went to see the doctor early because of health conditions. Zpak 5day supply and fluids. D3, C, Zinc, Antihistamine.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation irregular
Clinical narrative: Patient reported changes in her Menstrual Cycle, bleeding occurred earlier than usual.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Chest X-ray, Chest discomfort, Chest pain, Dyspnoea
Clinical narrative: Chest pain, Chest tightness, Shortness of breath, Pain worsens while lying down
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Chest pain, Chest tightness, Shortness of breath, Pain worsens while lying down
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Amenorrhoea, Blood urine present
Clinical narrative: I have not had a menstruation since the administration of the vaccine, when I urinate and dry myself I see pink blood. There are days that I stain a little and there are days that I don't.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood gases, Hyperventilation, Hypoaesthesia, Lethargy, Paraesthesia
Clinical narrative: On Monday, 8/30 after overcoming lethargy from the vaccine I developed numbness and tingling in both hands and forearms, this spread to lips, tongue and mouth by end of day Monday.   By Thursday, 9/2 even this became so intense that I visited the ER, and there they hypothesized it was potentially from the vaccine and to ride it out.  By Friday, 9/3 midday the numbness started in my left big toe.  This quickly moved to both big toes.  Each day since the paresthesia has spread further in both feet.  Today 9/9 it consumes all toes and the balls of both feet.  On 9/6 I went to the ER.  There they diagnosed that I was hyperventilating causing the the paresthesia to spread.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia oral, SARS-CoV-2 test, Urine analysis
Clinical narrative: On Monday, 8/30 after overcoming lethargy from the vaccine I developed numbness and tingling in both hands and forearms, this spread to lips, tongue and mouth by end of day Monday.   By Thursday, 9/2 even this became so intense that I visited the ER, and there they hypothesized it was potentially from the vaccine and to ride it out.  By Friday, 9/3 midday the numbness started in my left big toe.  This quickly moved to both big toes.  Each day since the paresthesia has spread further in both feet.  Today 9/9 it consumes all toes and the balls of both feet.  On 9/6 I went to the ER.  There they diagnosed that I was hyperventilating causing the the paresthesia to spread.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Extra dose administered, Guillain-Barre syndrome
Clinical narrative: On Monday, 8/30 after overcoming lethargy from the vaccine I developed numbness and tingling in both hands and forearms, this spread to lips, tongue and mouth by end of day Monday.   By Thursday, 9/2 even this became so intense that I visited the ER, and there they hypothesized it was potentially from the vaccine and to ride it out.  By Friday, 9/3 midday the numbness started in my left big toe.  This quickly moved to both big toes.  Each day since the paresthesia has spread further in both feet.  Today 9/9 it consumes all toes and the balls of both feet.  On 9/6 I went to the ER.  There they diagnosed that I was hyperventilating causing the the paresthesia to spread.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Pain, Pyrexia
Clinical narrative: Very Bad chest congestion that lasted 10 days, along with body aches and fever
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster, Scar
Clinical narrative: Was diagnosed with shingles. Under my left arm and on the left side of abdomen. Was given Valtrex.  To this day I still have some scaring as a result.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Lip pruritus, Pruritus, Throat irritation
Clinical narrative: itching to throat, ears, and lips that began 10 minutes after J&J Covid vaccine. Progressed to chest pain.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: She had Pfizer for her first dose.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Muscle spasms
Clinical narrative: Patient states having muscle spasms since first vaccination.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Palpitations
Clinical narrative: Began having heart palpitations, heart rate was 120 checked with pulse ox, has been ongoing off and on since vaccine
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Bacteraemia, Bacterial test, COVID-19, Chills, Cough
Clinical narrative: Janssen COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Janssen Vaccine on 3/11/2021. Presented to ED on 8/25/2021 with a 9-10 day history of coughing, fevers, diarrhea, fatigue, hypoxia, myalgiam and chills. She was started on Dexamethasone on 8/26 and continued this through her hospital course.  Eventually her oxygen requirements escalated and she required intubation on 8/27/21 due to persistent significant hypoxia despite maximum non-invasive interventions. A trialysis catheter was also placed for her and nephrology was consulted due to urgent need for dialysis as her kidney function continued to deteriorate since admission. Renal ultrasound did not show any hydronephrosis or obstructive processes.  On 8/27 she had 3L removed via HD. She required paralytics, sedation, and pain control while on the ventilator. On 8/27/21, her code status was changed to DNAR/COT. Eventually, she developed septic shock and was found later to be bacteremic (GPC in clusters) with a positive MRSA PCR nares. The culture did not have a final result by the time of her passing. She was started on broad spectrum antibiotics on 8/30 at the time of her becoming more septic.  On 8/31, the patient's MAPs and oxygen saturations continued to decrease despite maximal therapy (including four vasopressors). The patient passed away at 0630 on 8/31/21.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Death, Diarrhoea, Endotracheal intubation, Fatigue, Haemodialysis
Clinical narrative: Janssen COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Janssen Vaccine on 3/11/2021. Presented to ED on 8/25/2021 with a 9-10 day history of coughing, fevers, diarrhea, fatigue, hypoxia, myalgiam and chills. She was started on Dexamethasone on 8/26 and continued this through her hospital course.  Eventually her oxygen requirements escalated and she required intubation on 8/27/21 due to persistent significant hypoxia despite maximum non-invasive interventions. A trialysis catheter was also placed for her and nephrology was consulted due to urgent need for dialysis as her kidney function continued to deteriorate since admission. Renal ultrasound did not show any hydronephrosis or obstructive processes.  On 8/27 she had 3L removed via HD. She required paralytics, sedation, and pain control while on the ventilator. On 8/27/21, her code status was changed to DNAR/COT. Eventually, she developed septic shock and was found later to be bacteremic (GPC in clusters) with a positive MRSA PCR nares. The culture did not have a final result by the time of her passing. She was started on broad spectrum antibiotics on 8/30 at the time of her becoming more septic.  On 8/31, the patient's MAPs and oxygen saturations continued to decrease despite maximal therapy (including four vasopressors). The patient passed away at 0630 on 8/31/21.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, Mechanical ventilation, Myalgia, Pyrexia, Renal impairment
Clinical narrative: Janssen COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Janssen Vaccine on 3/11/2021. Presented to ED on 8/25/2021 with a 9-10 day history of coughing, fevers, diarrhea, fatigue, hypoxia, myalgiam and chills. She was started on Dexamethasone on 8/26 and continued this through her hospital course.  Eventually her oxygen requirements escalated and she required intubation on 8/27/21 due to persistent significant hypoxia despite maximum non-invasive interventions. A trialysis catheter was also placed for her and nephrology was consulted due to urgent need for dialysis as her kidney function continued to deteriorate since admission. Renal ultrasound did not show any hydronephrosis or obstructive processes.  On 8/27 she had 3L removed via HD. She required paralytics, sedation, and pain control while on the ventilator. On 8/27/21, her code status was changed to DNAR/COT. Eventually, she developed septic shock and was found later to be bacteremic (GPC in clusters) with a positive MRSA PCR nares. The culture did not have a final result by the time of her passing. She was started on broad spectrum antibiotics on 8/30 at the time of her becoming more septic.  On 8/31, the patient's MAPs and oxygen saturations continued to decrease despite maximal therapy (including four vasopressors). The patient passed away at 0630 on 8/31/21.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sepsis, Septic shock, Staphylococcus test positive, Ultrasound kidney normal
Clinical narrative: Janssen COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Janssen Vaccine on 3/11/2021. Presented to ED on 8/25/2021 with a 9-10 day history of coughing, fevers, diarrhea, fatigue, hypoxia, myalgiam and chills. She was started on Dexamethasone on 8/26 and continued this through her hospital course.  Eventually her oxygen requirements escalated and she required intubation on 8/27/21 due to persistent significant hypoxia despite maximum non-invasive interventions. A trialysis catheter was also placed for her and nephrology was consulted due to urgent need for dialysis as her kidney function continued to deteriorate since admission. Renal ultrasound did not show any hydronephrosis or obstructive processes.  On 8/27 she had 3L removed via HD. She required paralytics, sedation, and pain control while on the ventilator. On 8/27/21, her code status was changed to DNAR/COT. Eventually, she developed septic shock and was found later to be bacteremic (GPC in clusters) with a positive MRSA PCR nares. The culture did not have a final result by the time of her passing. She was started on broad spectrum antibiotics on 8/30 at the time of her becoming more septic.  On 8/31, the patient's MAPs and oxygen saturations continued to decrease despite maximal therapy (including four vasopressors). The patient passed away at 0630 on 8/31/21.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Vascular catheterisation
Clinical narrative: Janssen COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Janssen Vaccine on 3/11/2021. Presented to ED on 8/25/2021 with a 9-10 day history of coughing, fevers, diarrhea, fatigue, hypoxia, myalgiam and chills. She was started on Dexamethasone on 8/26 and continued this through her hospital course.  Eventually her oxygen requirements escalated and she required intubation on 8/27/21 due to persistent significant hypoxia despite maximum non-invasive interventions. A trialysis catheter was also placed for her and nephrology was consulted due to urgent need for dialysis as her kidney function continued to deteriorate since admission. Renal ultrasound did not show any hydronephrosis or obstructive processes.  On 8/27 she had 3L removed via HD. She required paralytics, sedation, and pain control while on the ventilator. On 8/27/21, her code status was changed to DNAR/COT. Eventually, she developed septic shock and was found later to be bacteremic (GPC in clusters) with a positive MRSA PCR nares. The culture did not have a final result by the time of her passing. She was started on broad spectrum antibiotics on 8/30 at the time of her becoming more septic.  On 8/31, the patient's MAPs and oxygen saturations continued to decrease despite maximal therapy (including four vasopressors). The patient passed away at 0630 on 8/31/21.
Age: 57.0
Sex: F
Vaccine: COVID19, MMR
Symptoms: Muscular weakness
Clinical narrative: Weakened muscle strength
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Polymerase chain reaction positive
Clinical narrative: Positive rapid PCR completed
Age: 41.0
Sex: F
Vaccine: UNK
Symptoms: Dyspnoea, Mobility decreased, Pain
Clinical narrative: Body pains, shortness of breath, unable to move arm
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Musculoskeletal stiffness, Pain, Pulmonary pain, Pyrexia
Clinical narrative: Headache, fever,  body aches, right sided pain, neck stiffness, lower lung pain that seems to be worsening after 24 mark rather than improving
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Nausea, Pyrexia, Vomiting
Clinical narrative: Fever, chills, nausea, vomitting, loss of appetite, loss of weight.  Unable to keep food or liquid down.  First day had very bad chills; the other symptoms lasted for total of four days.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Weight decreased
Clinical narrative: Fever, chills, nausea, vomitting, loss of appetite, loss of weight.  Unable to keep food or liquid down.  First day had very bad chills; the other symptoms lasted for total of four days.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Resident had a breakthrough case of COVID-19 after receiving both doses of the Pfizer Vaccine.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Cough, Fatigue
Clinical narrative: Dry Cough, Lost Taste and Smell, Other  Fatigue